苯酰胺,2-甲酰基-N-苯基- | 106149-47-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 苯酰胺,2-甲酰基-N-苯基-
• 英文名称: 2-Formyl-N-phenylbenzamide
• CAS: 106149-47-7
• 化学式: C₁₄H₁₁NO₂
• 分子量: 225.24
• InChiKey: SQNDAMRRWAMHSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(2-hydroxy-5-methyl-3-nitrophenyl)-3-(4-nitrophenyl)propane-1,3-dione 、 苯酰胺,2-甲酰基-N-苯基- 、 哌啶 生成 2-[(Z)-2-(2-hydroxy-5-methyl-3-nitrobenzoyl)-3-(4-nitrophenyl)-3-oxoprop-1-enyl]-N-phenylbenzamide
  参考文献：
  名称：

  HOGALE M. B.; DHORE N. P.; SHELAR A. R.; PAWAR P. K., ORIENT J. CHEM., 2,(1986) N 1, 55-57

  摘要：

  DOI：

文献信息

• USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS
  申请人：Ligand Pharmaceuticals Incorporated

  公开号：EP2642994A2

  公开（公告）日：2013-10-02
• Crosslinkable Elastomer Composition and Molded Article Using the Same
  申请人：Nishibayashi Hirofumi

  公开号：US20090076197A1

  公开（公告）日：2009-03-19

  The present invention provides a crosslinkable elastomer composition, in which generation of HF under high temperature conditions is reduced, the decrease in weight to both NF 3 plasma treatment and O 3 treatment in the semiconductor manufacturing process is small and generation of foreign substances (particles) in these treatments is suppressed significantly. Specifically, the present invention relates to a crosslinkable elastomer composition comprising a crosslinkable elastomer and a filler having a specific surface area of at least 0.5 m 2 /g and containing a synthetic polymer having a thermally and chemically stable aromatic ring in the main chain, a crosslinkable elastomer composition comprising a crosslinkable elastomer and nonoxide ceramics and a crosslinkable elastomer composition wherein the decrease in weight by NF 3 plasma irradiation is at most 0.20%.
• US7495046B2
  申请人：——

  公开号：US7495046B2

  公开（公告）日：2009-02-24
• US8173727B2
  申请人：——

  公开号：US8173727B2

  公开（公告）日：2012-05-08
• [EN] USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS<br/>[FR] UTILISATION DE MIMÉTIQUES D'UN FACTEUR DE CROISSANCE HÉMATOPOÏÉTIQUE
  申请人：LIGAND PHARM INC

  公开号：WO2012068406A2

  公开（公告）日：2012-05-24

  The present invention relates to uses of small molecule mimetics of hematopoietic growth factors. In particular the present invention relates to uses of small molecule mimetics of erythropoietin.